1st Quarter - Report

BGR GOVERNMENT AFFAIRS for THE PROCTER & GAMBLE COMPANY

A later version of this report replaces this one, so LegiList's totals use the current version instead. This page shows this version exactly as filed.

Firm
Client
Income
—
Expenses
—

No amount is shown when the filer reports less than $5,000 for the period, which the form does not ask them to state.

Versions of this report

Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.

Filing Filed Amount Counted
1st Quarter - Report (this page) Jan 12, 2026 — Replaced
1st Quarter - Amendment Apr 20, 2026 $60,000 Yes

What was lobbied

One issue area, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Provide strategic counsel and advocate on issues related to OTC drug regulation, FDA, FTC, and healthcare policy

LobbyistCovered position, as disclosed
MARVIN BENITO FIGUEROA COS, Sen. Laphonza Butler; Dir. of Off. of Inter. Affairs and Ext. Affairs, HHS; Sen. Policy Adv., Leg. Asst., Leg. Aide, Leg. Corr., Sec. Edu. Grad. Fellow, Sen. Mark Warner; Intern, White House
REMY LEIGH BRIM MASON Senior FDA Policy Advisor to Senate HELP Committee Ranking Member Patty Murray; Senior Health Policy Advisor Sen. Elizabeth Warren; Intern to Rep. Allyson Schwartz
JOHN STONE Counsel, House E&C Cmte, Oversight Subcommittee; Senior Counsel, House E&C Cmte, Health Subcommittee; Intern, House E&C
SYD TERRY COS, Rep. Jan Schakowsky; Policy Coordinator for Energy & Commerce; LD, Rep. Jan Schakowsky; Sr. LA, Rep. Mark Pocan; LA for Rep Pocan, Intern Senator Salazar, Intern Senator Levin

Contacted: White House Office; Health & Human Services, Dept of (HHS); SENATE; Food & Drug Administration (FDA); HOUSE OF REPRESENTATIVES

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.